|
業務類別
|
Biotechnology |
|
業務概覽
|
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of patient-centric therapies that address serious unmet medical needs for those living with cardiometabolic and orphan lung diseases. The Companyis currently commercializing three products: Afrezza (insulin human) Inhalation Powder, an ultra rapid-acting inhaled insulin indicated to improve glycemic control in adults with diabetes; Furoscix (furosemide injection), to treat fluid buildup in patients with chronic heart failure or chronic kidney disease; and the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults that require insulin. |
| 公司地址
| 1 Casper Street, Danbury, CT, USA, 06810 |
| 電話號碼
| +1 818 661-5000 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.mannkindcorp.com |
| 員工數量
| 592 |
| Dr. David B. Thomson, J.D.,PhD |
Executive Vice President, General Counsel and Secretary |
美元 520.75K |
07/04/2026 |
| Dr. Stuart A. Tross, PhD |
Executive Vice President, Human Resources |
美元 438.71K |
07/04/2026 |
| Mr. Michael E. Castagna, Pharm.D. |
Director and Chief Executive Officer |
美元 789.44K |
07/04/2026 |
| Mr. Christopher B. Prentiss |
Chief Financial Officer and Principal Accounting Officer |
美元 470.09K |
07/04/2026 |
| Mr. Dominic Marasco |
President, Endocrine Business Unit |
美元 447.60K |
07/04/2026 |
| Dr. Ajay Ahuja, M.B.A.,M.D. |
Executive Vice President and Chief Medical Officer |
-- |
07/04/2026 |
| Mr. Sanjay R. Singh, M.B.A. |
Executive Vice President, Technical Operations |
-- |
07/04/2026 |
|
|
| Mr. Anthony C. Hooper |
Independent Director |
07/04/2026 |
| Dr. Michael A. Friedman M.D. |
Independent Director |
07/04/2026 |
| Mr. Ronald J. Consiglio |
Independent Director |
07/04/2026 |
| Dr. James S. Shannon, M.D.,M.R.C.P. |
Chairman of the Board |
07/04/2026 |
| Mr. Michael E. Castagna, Pharm.D. |
Director and Chief Executive Officer |
07/04/2026 |
| Mr. Steven B. Binder |
Director |
07/04/2026 |
| Ms. Christine A. Mundkur |
Independent Director |
07/04/2026 |
| Ms. Jennifer Grancio |
Independent Director |
07/04/2026 |
| Dr. Sabrina Kay, PhD |
Independent Director |
07/04/2026 |
|
|
|
|
